$SNTA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in MADRIGAL PHARMACEUTICALS, INC.. Get notifications about new insider transactions in MADRIGAL PHARMACEUTICALS, INC. for free.

Page:   < prev 1 2 3 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 15 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.32300,00096,6901,539,1691.8 M to 1.5 M (-16.31 %)
Dec 15 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.37300,000111,0301,839,1692.1 M to 1.8 M (-14.02 %)
Dec 09 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.38145,89255,2352,139,1692.3 M to 2.1 M (-6.38 %)
Dec 09 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.38300,000114,0602,285,0612.6 M to 2.3 M (-11.61 %)
Dec 09 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.39300,000115,8302,585,0612.9 M to 2.6 M (-10.40 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.37496,015183,526340,970837 K to 341 K (-59.26 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.37873,624323,241600,5481.5 M to 600.5 K (-59.26 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.413615836,985837 K to 837 K (0.00 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4164261,474,1721.5 M to 1.5 M (0.00 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4155,62922,941837,021892.7 K to 837 K (-6.23 %)
Dec 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4197,97840,4061,474,2361.6 M to 1.5 M (-6.23 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4195,04039,337892,650987.7 K to 892.7 K (-9.62 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.41167,39469,2841,572,2141.7 M to 1.6 M (-9.62 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43249,015106,379987,6901.2 M to 987.7 K (-20.14 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43438,588187,3651,739,6082.2 M to 1.7 M (-20.14 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43174,09174,8941,236,7051.4 M to 1.2 M (-12.34 %)
Dec 03 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43306,625131,9102,178,1962.5 M to 2.2 M (-12.34 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43231,959100,5541,410,7961.6 M to 1.4 M (-14.12 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43408,546177,1052,484,8212.9 M to 2.5 M (-14.12 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.50338,463167,5391,642,7552 M to 1.6 M (-17.08 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.50596,132295,0852,893,3673.5 M to 2.9 M (-17.08 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.49544,571265,8051,981,2182.5 M to 2 M (-21.56 %)
Nov 30 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.49959,149468,1613,489,4994.4 M to 3.5 M (-21.56 %)
Nov 24 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.44194,88386,0022,525,7892.7 M to 2.5 M (-7.16 %)
Nov 24 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.44343,246151,4744,448,6484.8 M to 4.4 M (-7.16 %)
Nov 24 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.44230,129100,5432,720,6723 M to 2.7 M (-7.80 %)
Nov 24 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.44405,324177,0864,791,8945.2 M to 4.8 M (-7.80 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4483,39736,9532,950,8013 M to 3 M (-2.75 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.44146,88665,0855,197,2185.3 M to 5.2 M (-2.75 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4665,80230,3813,034,1983.1 M to 3 M (-2.12 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.46115,89653,5095,344,1045.5 M to 5.3 M (-2.12 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.51992,953501,4410993 K to 0 (-100.00 %)
Nov 20 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43108,15446,820992,9531.1 M to 993 K (-9.82 %)
Nov 19 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorSellS0.41100,00041,4002,885,0613 M to 2.9 M (-3.35 %)
Nov 17 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.42700,618295,6611,101,1071.8 M to 1.1 M (-38.89 %)
Nov 17 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.4415,5306,7591,801,7251.8 M to 1.8 M (-0.85 %)
Nov 17 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.43507,788219,5681,817,2552.3 M to 1.8 M (-21.84 %)
Nov 12 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorBuyS0.55188,322103,0502,985,0612.8 M to 3 M (+6.73 %)
Nov 12 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.47733,564347,7832,325,0433.1 M to 2.3 M (-23.98 %)
Nov 12 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.501,080,941538,2013,058,6074.1 M to 3.1 M (-26.11 %)
Nov 12 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.551,397,114769,1114,139,5485.5 M to 4.1 M (-25.23 %)
Nov 12 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellS0.612,225,0541,354,1685,536,6627.8 M to 5.5 M (-28.67 %)
Nov 05 2015SNTASYNTA PHARMACEUTIC ...Morenstein Scott DDirectorOption ExerciseA0.6740,00026,80040,000
Oct 06 2015SNTASYNTA PHARMACEUTIC ...Rieder Wendy ESVP, Gen. CounselOption ExerciseA1.76250,000440,000250,000
Oct 06 2015SNTASYNTA PHARMACEUTIC ...Vukovic VojoSVP, Chief Medical ...Option ExerciseA1.76132,300232,848132,300
Oct 06 2015SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RSVP and CFOOption ExerciseA1.76153,100269,456153,100
Oct 06 2015SNTASYNTA PHARMACEUTIC ...Schor ChenPresident and CEOOption ExerciseA1.76250,000440,000250,000
Oct 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.004,000,000011,399,46415.4 M to 11.4 M (-25.97 %)
Oct 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyJ0.004,000,00004,000,0000 to 4 M
Oct 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00120,85400120.9 K to 0 (-100.00 %)
Oct 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyJ0.00120,854015,399,46415.3 M to 15.4 M (+0.79 %)
Sep 18 2015SNTASYNTA PHARMACEUTIC ...Schor ChenPresident and CEOOption ExerciseA2.02500,0001,010,000500,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...KUFE DONALD WDirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA2.2015,00033,00015,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.004,5450401,764397.2 K to 401.8 K (+1.14 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.004,5450397,219392.7 K to 397.2 K (+1.16 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.004,5450392,674388.1 K to 392.7 K (+1.17 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.0013,6360388,129374.5 K to 388.1 K (+3.64 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.0022,7270374,493351.8 K to 374.5 K (+6.46 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorGrantA0.006,8180760,936754.1 K to 760.9 K (+0.90 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.001,13606,8175.7 K to 6.8 K (+20.00 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorGrantA0.005,68105,6810 to 5.7 K
Jul 06 2015SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorOption ExerciseA2.2020,00044,00020,000
Jul 06 2015SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorGrantA0.002,272049,39247.1 K to 49.4 K (+4.82 %)
Jul 06 2015SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorGrantA0.005,681047,12041.4 K to 47.1 K (+13.71 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorOption ExerciseA2.2020,00044,00020,000
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.004,54503,092,6773.1 M to 3.1 M (+0.15 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.004,54503,088,1323.1 M to 3.1 M (+0.15 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.0022,72703,083,5873.1 M to 3.1 M (+0.74 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00354,1460120,854475 K to 120.9 K (-74.56 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00475,00000475 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00475,00000475 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00475,00000475 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00125,00000125 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00125,00000125 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorSellJ0.00250,00000250 K to 0 (-100.00 %)
Jul 02 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyJ0.002,279,14602,279,1460 to 2.3 M
Jun 08 2015SNTASYNTA PHARMACEUTIC ...Schor ChenPresident and CEOOption ExerciseA2.40500,0001,200,000500,000
Jun 08 2015SNTASYNTA PHARMACEUTIC ...Schor ChenPresident and CEOGrantA0.00150,0000300,000150 K to 300 K (+100.00 %)
Apr 08 2015SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP1.756,857,14312,000,00015,278,6108.4 M to 15.3 M (+81.42 %)
Apr 08 2015SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorBuyP1.75350,000612,5003,173,3832.8 M to 3.2 M (+12.40 %)
Apr 08 2015SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorBuyP1.7550,00087,500754,118704.1 K to 754.1 K (+7.10 %)
Mar 04 2015SNTASYNTA PHARMACEUTIC ...Rieder Wendy ESVP, Gen. CounselOption ExerciseA2.38100,000238,000100,000
Mar 04 2015SNTASYNTA PHARMACEUTIC ...McMahon ArthurSVP, Human Resource ...Option ExerciseA2.38126,768301,708126,768
Mar 04 2015SNTASYNTA PHARMACEUTIC ...Vukovic VojoSVP, Chief Medical ...Option ExerciseA2.38173,280412,406173,280
Mar 04 2015SNTASYNTA PHARMACEUTIC ...Whitaker Anne ClemPresident and CEOOption ExerciseA2.38100,000238,000100,000
Dec 10 2014SNTASYNTA PHARMACEUTIC ...Schor ChenExecutive VP and CO ...Option ExerciseA2.85450,0001,282,500450,000
Dec 10 2014SNTASYNTA PHARMACEUTIC ...Schor ChenExecutive VP and CO ...GrantA0.00150,0000150,0000 to 150 K
Dec 10 2014SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RSVP and CFOOption ExerciseA2.85225,000641,250225,000
Dec 10 2014SNTASYNTA PHARMACEUTIC ...Schneebaum Marc RSVP and CFOGrantA0.0075,000075,0000 to 75 K
Oct 01 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP3.08300,000923,1308,421,4678.1 M to 8.4 M (+3.69 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.001,21903,060,8603.1 M to 3.1 M (+0.04 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.001,21903,059,6413.1 M to 3.1 M (+0.04 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.009,75603,058,4223 M to 3.1 M (+0.32 %)
Sep 04 2014SNTASYNTA PHARMACEUTIC ...Whitaker Anne ClemPresident and CEOOption ExerciseA4.00250,0001,000,000250,000
Sep 04 2014SNTASYNTA PHARMACEUTIC ...Whitaker Anne ClemPresident and CEOOption ExerciseA4.00500,0002,000,000500,000
Sep 04 2014SNTASYNTA PHARMACEUTIC ...Whitaker Anne ClemPresident and CEOGrantA0.00500,0000500,0000 to 500 K
Jul 03 2014SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA4.104,50018,4504,500
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.001,2190351,766350.5 K to 351.8 K (+0.35 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.001,2190350,547349.3 K to 350.5 K (+0.35 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.002,4390349,328346.9 K to 349.3 K (+0.70 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.004,8780346,889342 K to 346.9 K (+1.43 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.009,7560342,011332.3 K to 342 K (+2.94 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorGrantA0.004,878041,43936.6 K to 41.4 K (+13.34 %)
Jul 03 2014SNTASYNTA PHARMACEUTIC ...KUFE DONALD WDirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorOption ExerciseA4.1010,00041,00010,000
Jul 03 2014SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorGrantA0.002,4390704,118701.7 K to 704.1 K (+0.35 %)
Apr 14 2014SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.011,250,0005,012,5008,121,4676.9 M to 8.1 M (+18.19 %)
Mar 05 2014SNTASYNTA PHARMACEUTIC ...McMahon ArthurSVP, People Operati ...Option ExerciseA6.15115,000707,250115,000
Mar 05 2014SNTASYNTA PHARMACEUTIC ...Vukovic VojoSVP, Chief Medical ...Option ExerciseA6.15141,211868,448141,211
Mar 05 2014SNTASYNTA PHARMACEUTIC ...Rieder Wendy EVP, IP and Legal, G ...Option ExerciseA6.1566,512409,04966,512
Mar 05 2014SNTASYNTA PHARMACEUTIC ...Ehrlich Keith SVP, Fin. and Admin. ...Option ExerciseA6.1566,985411,95866,985
Mar 05 2014SNTASYNTA PHARMACEUTIC ...FRIEDMAN PAUL ADirectorOption ExerciseA6.1520,000123,00020,000
Dec 20 2013SNTASYNTA PHARMACEUTIC ...Bernitz Steven BSVP, Corporate Deve ...Option ExerciseA4.34150,000651,000150,000
Dec 20 2013SNTASYNTA PHARMACEUTIC ...Bernitz Steven BSVP, Corporate Deve ...GrantA0.0025,000325,0000 to 25 K
Nov 15 2013SNTASYNTA PHARMACEUTIC ...Bahcall Safi RPresident and CEOBuyP3.7520,00075,0002,053,1352 M to 2.1 M (+0.98 %)
Nov 15 2013SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorBuyP3.7513,33349,99936,56123.2 K to 36.6 K (+57.40 %)
Nov 15 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorBuyP3.75150,000562,5002,823,3832.7 M to 2.8 M (+5.61 %)
Nov 15 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP3.753,400,00012,750,0007,649,8034.2 M to 7.6 M (+80.00 %)
Nov 15 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP3.751,600,0006,000,0001,600,0000 to 1.6 M
Jul 03 2013SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorOption ExerciseA5.0010,00050,00010,000
Jul 03 2013SNTASYNTA PHARMACEUTIC ...REARDON WILLIAM SDirectorGrantA0.004,000023,22819.2 K to 23.2 K (+20.80 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorOption ExerciseA5.0010,00050,00010,000
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.001,00006,180,3306.2 M to 6.2 M (+0.02 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.001,00006,179,3306.2 M to 6.2 M (+0.02 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorGrantA0.008,00006,178,3306.2 M to 6.2 M (+0.13 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA5.004,50022,5004,500
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorOption ExerciseA5.0010,00050,00010,000
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.001,0000332,255331.3 K to 332.3 K (+0.30 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.001,0000331,255330.3 K to 331.3 K (+0.30 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.002,0000330,255328.3 K to 330.3 K (+0.61 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.004,0000328,255324.3 K to 328.3 K (+1.23 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...Gollust Keith RDirectorGrantA0.008,0000324,255316.3 K to 324.3 K (+2.53 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorOption ExerciseA5.0010,00050,00010,000
Jul 03 2013SNTASYNTA PHARMACEUTIC ...WILSON ROBERT NDirectorGrantA0.002,0000701,679699.7 K to 701.7 K (+0.29 %)
Jul 03 2013SNTASYNTA PHARMACEUTIC ...KUFE DONALD WDirectorOption ExerciseA5.0010,00050,00010,000
Jul 03 2013SNTASYNTA PHARMACEUTIC ...KUFE DONALD WDirectorGrantA0.008,000025,74817.7 K to 25.7 K (+45.08 %)
Jul 01 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.71150,000706,5153,100,0003 M to 3.1 M (+5.08 %)
Jul 01 2013SNTASYNTA PHARMACEUTIC ...Bahcall Safi RPresident and CEOBuyP5.0310,00050,2992,033,1352 M to 2 M (+0.49 %)
Jun 27 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.65300,0001,395,9302,950,0002.7 M to 3 M (+11.32 %)
Jun 27 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.35200,000869,4602,650,0002.5 M to 2.7 M (+8.16 %)
Jun 25 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.2350,000211,5202,250,0002.2 M to 2.3 M (+2.27 %)
Jun 25 2013SNTASYNTA PHARMACEUTIC ...Kovner BruceDirectorBuyP4.43200,000885,9202,450,0002.3 M to 2.5 M (+8.89 %)

Page:   < prev 1 2 3 4 next >